World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), Scope Database, 



*Dr. Raja Nakhli, Ghita Elghouat, Hicham Yahyaoui and Mohamed Chakour


Introduction: Chronic lymphoproliferative disorders (CLPD) are an heterogeneous group of diseases characterized by uncontroled production of lymphocytes that cause clonal lymphocytosis, lymphadenopathy, and bone marrow infiltration. Methods: A retrospective analysis (2014 to 2020) was carried out on the basis of 99 patients with lymphoproliferative disorders in the Laboratory of hematology of the Avicenne military hospital in Marrakech to describe the epidemiological, clinical, cytological characteristics of lymphoproliferative disorders. Results: Among 99 registered cases, there were 62 cases of multiple myeloma (MM) (62,62 %), 32 cases of chronic lymphoid leukemia (CLL) (32,3%), 3 cases of Sézary syndrome (SS) (3 %), a single case of Hairy Cells Leukemia (HCL) (1%) and a single case of prolymphocytic leukemia(LPB) (1%) were described. The median age of the patients was 61 (range: 41 to 80) years. There were 76 males (76%) and 23 females (24%), Male-to-female sex ratio was 3. Myelomas are the most frequently encountered in our series,bone pain is present in 78% of multiple myeloma patients, 6% have vertebral compression and 7% present chronic renal failure. Monoclonal gammopathy with kappa-type IgG is found in 60% of cases, IgG lambda in 26% of cases, IgA kappa in 5% of cases, IgM kappa in 4% of cases, and kappa light chains in 5% of cases.We found 32 cases of CLL, the average age is 65 years with extremes ranging from 45 to 78 years with a sex ratio of 5. Peripheral lymphadenopathy is the most frequent revealing symptom of the disease in 31 cases (50%) associated with splenomegaly in 2 cases, 45 % of cases were clinically asymptomatic. Conclusions: This retrospective study provides a clinical, epidemiological and cytological description of lymphoproliferative disorders in 101 cases

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here